IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior.
Neuron
; 85(3): 519-33, 2015 Feb 04.
Article
em En
| MEDLINE
| ID: mdl-25619653
ABSTRACT
Anti-inflammatory strategies are proposed to have beneficial effects in Alzheimer's disease. To explore how anti-inflammatory cytokine signaling affects Aß pathology, we investigated the effects of adeno-associated virus (AAV2/1)-mediated expression of Interleukin (IL)-10 in the brains of APP transgenic mouse models. IL-10 expression resulted in increased Aß accumulation and impaired memory in APP mice. A focused transcriptome analysis revealed changes consistent with enhanced IL-10 signaling and increased ApoE expression in IL-10-expressing APP mice. ApoE protein was selectively increased in the plaque-associated insoluble cellular fraction, likely because of direct interaction with aggregated Aß in the IL-10-expressing APP mice. Ex vivo studies also show that IL-10 and ApoE can individually impair glial Aß phagocytosis. Our observations that IL-10 has an unexpected negative effect on Aß proteostasis and cognition in APP mouse models demonstrate the complex interplay between innate immunity and proteostasis in neurodegenerative diseases, an interaction we call immunoproteostasis.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Imunoproteínas
/
Interleucina-10
/
Precursor de Proteína beta-Amiloide
/
Transtornos Cognitivos
/
Placa Amiloide
/
Deficiências na Proteostase
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article